Asia Pacific Precision Medicine Market Size & Outlook
Asia Pacific precision medicine market, 2018-2030 (US$M)
Related Markets
Asia Pacific precision medicine market highlights
- The Asia Pacific precision medicine market generated a revenue of USD 15,578.2 million in 2023.
- The market is expected to grow at a CAGR of 20.5% from 2024 to 2030.
- In terms of segment, therapeutics was the largest revenue generating application in 2023.
- Diagnostics is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 15,578.2 million |
| Market revenue in 2030 | USD 57,313.9 million |
| Growth rate | 20.5% (CAGR from 2023 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 17.8% of the global precision medicine market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 57,313.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Precision Medicine Market Scope
Precision Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific precision medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 74.46% in 2023. Horizon Databook has segmented the Asia Pacific precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The Personalised Health Index, developed by leading public health experts and Roche, measures the readiness of 11 regions across Asia Pacific in personalized care. It helps stakeholders identify local, national, and regional strengths and opportunities for improvement and collaboration.
These insights enable healthcare and policy leaders to prioritize efforts, embrace emerging changes in healthcare like telehealth solutions, and facilitate data-driven decision-making, such as genomic profiling for cancer treatment. Despite rising healthcare costs and growing populations, Asia Pacific has the potential to lead in personalized healthcare.
The index reveals significant momentum in this field across the region. Singapore is the highest performer in personalized healthcare readiness, owing to its national precision medicine program, the 3 Beyonds program, a robust digital infrastructure, and high uptake of technologies like Electronic Health Records (EHRs) and Artificial Intelligence (AI).
Reasons to subscribe to Asia Pacific precision medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific precision medicine market databook
-
Our clientele includes a mix of precision medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific precision medicine diagnostics therapeutics market size, by country, 2018-2030 (US$M)
Asia Pacific Precision Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
